Aspen joins Africa push to make MSD’s once-a-month HIV prevention pill
Local production would strengthen healthcare security across the continent and reduce reliance on imported medicines.
-
-
Somebody call Hasina
Amid the mostly depressing HIV headlines of recent times, concerned as they mainly are with the deadly impacts of donor defunding, South Africa’s imminent roll-out of a twice-yearly HIV prevention injection called lenacapavir (LEN) has been a spot of bright light. Staff in 360 healthcare facilities spread across the country stand trained and ready to…
-
Advocacy for Prevention of HIV and Aids | Aids and Malaria | Global Fund to Fight TB | Health | HIV Prevention Jab | lenacapavir
Our anti-HIV jab will be rolled out in six weeks. But funding cuts hollowed out the system needed to deliver it
South Africa’s uptake of the once-every-six-month HIV prevention jab, lenacapavir (LEN), will be heavily affected by the Trump administration’s funding cuts to the country because it destroyed much of the infrastructure — such as community-based testing and field recruitment for HIV prevention services — needed to create demand for the medicine. That’s one of the…
-
Featured | HIV Prevention | lenacapavir | News | PEPFAR | US-SA Funding
Lenacapavir rollout in South Africa and PEPFAR builds momentum
South Africa’s battle against HIV is gaining renewed momentum as the government prepares to introduce the rollout of lenacapavir. Lenacapavir is a long-acting injectable prevention method that provides six months of protection with just two doses in a year. Health Minister Dr Aaron Motsoaledi confirmed that the government has planned for the first phase of…